Stay updated on Flotetuzumab in PIF/ER AML Clinical Trial

Sign up to get notified when there's something new on the Flotetuzumab in PIF/ER AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Flotetuzumab in PIF/ER AML Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The footer’s site revision identifier was updated from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-11T14:15:29.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    The study record page now shows a 403 Forbidden error, indicating access is blocked. The additions include the HTML structure of a 403 page (title, header, and footer) rather than substantive study details.
    Difference
    21%
    Check dated 2026-09-20T20:25:41.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    The page now shows revision v3.6.6, replacing the previous v3.6.5. This reflects a small deployment update with no documented changes to the study details or eligibility criteria.
    Difference
    0.0%
    Check dated 2026-08-30T21:43:29.000Z thumbnail image
  6. Check
    68 days ago
    Change Detected
    Summary
    The study page now displays a server error page with a basic HTML frame. This replaces the full study record and related content on the page.
    Difference
    20%
    Check dated 2026-08-09T11:19:50.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    The page revision tag was updated from v3.6.3 to v3.6.4, signaling a small backend/content update with no visible changes to the study details shown to users.
    Difference
    0.0%
    Check dated 2026-07-26T00:08:40.000Z thumbnail image
  8. Check
    104 days ago
    Change Detected
    Summary
    Page build updated from v3.6.2 to v3.6.3. This reflects a new release of the page rather than content changes.
    Difference
    0.0%
    Check dated 2026-07-04T13:32:51.000Z thumbnail image

Stay in the know with updates to Flotetuzumab in PIF/ER AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Flotetuzumab in PIF/ER AML Clinical Trial page.